Plasma circN4BP2L2 is significantly downregulated in EOC and might serve as a promising novel diagnostic biomarker for EOC patients, especially in early stage EOC cases..
Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.